Cargando…
Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus that uses the human angiotensin-converting enzyme 2 (ACE2) receptor as a point of entry. The present review discusses the origin and structure of the virus and its mechanism of cell entry followed by the therapeutic p...
Autores principales: | Sharifkashani, Sourena, Bafrani, Melika Arab, Khaboushan, Alireza Soltani, Pirzadeh, Marzieh, Kheirandish, Ali, Yavarpour_Bali, Hanie, Hessami, Amirhossein, Saghazadeh, Amene, Rezaei, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834210/ https://www.ncbi.nlm.nih.gov/pubmed/32745604 http://dx.doi.org/10.1016/j.ejphar.2020.173455 |
Ejemplares similares
-
Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders
por: Yavarpour-Bali, Hanie, et al.
Publicado: (2019) -
Stem Cell-based Therapeutic and Diagnostic Approaches in Alzheimer's Disease
por: Abdi, Sadaf, et al.
Publicado: (2022) -
An overview of possible solutions putting an end to the COVID-19 pandemic
por: Adiban Afkham, Saina, et al.
Publicado: (2022) -
Update on neurological manifestations of COVID-19
por: Yavarpour-Bali, Hanie, et al.
Publicado: (2020) -
SARS-CoV-2–A Tough Opponent for the Immune System
por: Nasab, Mahsa Golshani, et al.
Publicado: (2020)